-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Acurx Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2023.
- Acurx Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$2.82M, a 9.42% increase year-over-year.
- Acurx Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$16.4M, a 29.2% decline year-over-year.
- Acurx Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$14.6M, a 20.5% decline from 2022.
- Acurx Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$12.1M, a 5.14% increase from 2021.
- Acurx Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$12.7M, a 177% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)